Epigenetic Alteration of the Wnt Inhibitory Factor-1 Promoter Is Common and Occurs in Advanced Stage of Tunisian Nasopharyngeal Carcinoma

REFERENCES

• Nicholls, J.M.; Agathanggelou, A.; Fung, K.; Zeng, X.; Niedobitek, G. The association of squamous cell carcinomas of the nasopharynx with Epstein-Barr virus shows geographical variation reminiscent of Burkitt's lymphoma. J Pathol 1997, 183, 164–168.
   PubMed Web of Science ®Google Scholar
• Busson, P.; Keryer, C.; Ooka, T.; Corbex, M. EBV-associated nasopharyngeal carcinomas: from epidemiology to virus-targeting strategies. Trends Microbiol 2004, 12, 356–360.
   PubMed Web of Science ®Google Scholar
• Kammoun, M.; Vogt-Hoerner, G.; Mourali, N. Tumors of the nasopharynx in Tunisia: an anatomic and clinical study based on 143 cases. Cancer 1974, 33, 184–191.
   PubMed Web of Science ®Google Scholar
• Khabir, A.; Sellami, A.; Sakka, M.; Ghorbe, A.M.; Daoud, J.; Frikha, M.; Drira, M.; Busson, P.; Jlidi, R. Contrasted frequencies of p53 accumulation in the two age groups of North African nasopharyngeal carcinomas. Clin Cancer Res 2000, 6, 3932– 3936.
   PubMed Web of Science ®Google Scholar
• Daoud, J.; Toumi, N.; Bouaziz, M.; Ghorbel, A.M.; Jlidi, R.; Drira, M.; Frikha M. Nasopharyngeal carcinoma in childhood and adolescence: analysis of a series of 32 patients treated with combined chemotherapy and radiotherapy. Eur J Cancer 2003, 39, 2349–2354.
   PubMed Web of Science ®Google Scholar
• Chang, E.T.; Hans-Olov, A. The enigmatic epidemiology of nasopharyngeal carcinoma. Cancer Epidemiol Biomarkers Prev 2006, 15, 335–339.
   Google Scholar
• Feng, B.J.; Jalbout, M.; Ben Ayoub, W.; Khyatti, M.; Dahmoul, S.;Ayad, M.; Maachi, F.; Bedadra, W.; Abdoun, M.; Mesli, S.; Hamdi-Cherif, M.; Boualga, K.; Bouaouina, N.; Chouchane, L.; Benider, A.; Ben Ayed, F.; Goldgar, D.; Corbex, M. Dietary risk factors for nasopharyngeal carcinoma in Maghrebian countries. Int J Cancer 2007, 121, 1550–1555.
   PubMed Web of Science ®Google Scholar
• Lo, K.W.; To, K.F.; Huang, D.P. Focus on nasopharyngeal carcinoma. Cancer Cell 2004, 39, 2349–2354.
   Google Scholar
• Jones, P.A.; Baylin, S.B. The fundamental role of epigenetic events in cancer. Nat Rev Genet 2002, 3, 415–428.
   PubMed Web of Science ®Google Scholar
• Akiyama, T. Wnt/beta-catenin signaling. Cytokine Growth Factor Rev 2000, 11, 273–282.
   PubMed Web of Science ®Google Scholar
• Seidensticker, M.J.; Behrens, J. Biochemical interactions in the Wnt pathway. Biochim Biophys Acta 2000, 495, 168–182.
   Google Scholar
• Yamaguchi, T.P. Heads or tails: Wnts and anterior-posterior patterning. Curr Biol 2001, 11, 713–724.
   PubMed Web of Science ®Google Scholar
• Morin, P.J.; Sparks, A.B.; Korinek, V.; Barker, N.; Clevers, H. Activation of beta-catenin-Tcf signaling in colon cancer by mutations in beta-catenin or APC. Science 1997, 275, 1787–1790.
   PubMed Web of Science ®Google Scholar
• Weeraratna, A.T.; Jiang, Y.; Hostetter, G.; Rosenblatt, K.; Duray, P.; Bittner, M.; Trent, J.M. Wnt5a signaling directly affects cell motility and invasion of metastatic melanoma. Cancer Cell 2002, 58, 279–288.
   Google Scholar
• Uematsu, K.; He, B.; You, L.; Xu, Z.; Mcormick, F.; Jablons, D.M. Activation of the Wnt pathway in non-small cell lung cancer: evidence of dishevelled overexpression. Oncogene 2003, 22, 7218–7221.
   PubMed Web of Science ®Google Scholar
• Lu, D.; Zhao, Y.; Tawatao, R.; Cottam, H.B.; Sen, M.; Leoni, L.M.; Kipps, T.J.; Corr, M. Activation of the Wnt signaling pathway in chronic lymphocytic leukemia. Proc Natl Acad Sci USA 2004, 101, 3118–3123.
   PubMed Web of Science ®Google Scholar
• Rhee, C.S.; Sen, M.; Lu, D.; Wu, C.; Leoni, L.; Rubin, J.; Corr, M. Wnt and frizzled receptors as potential targets for immunotherapy in head and neck squamous cell carcinomas. Oncogene 2002, 21, 6598–6605.
   PubMed Web of Science ®Google Scholar
• Lee, A.Y.; He, B.; You, L.; Dadfarmay, S.; Xu, Z.; Mazieres, J.; Mikami, I.; Cormick, F.; Jablons, D.M. Expression of the secreted frizzled-related protein gene family is downregulated in human mesothelioma. Oncogene 2004, 23, 6672–6676.
   PubMed Web of Science ®Google Scholar
• Holmen, S.L.; Salic, A.; Zylstra, C.R.; Kirschner, M.W.; Williams, B.O. A novel set of Wnt-frizzled fusion proteins identifies receptor components that activate beta-caten independent signaling. J Biol Chem 2002, 277, 34727–34735.
   PubMed Web of Science ®Google Scholar
• Nusse, R.; Varmus, H.E. Wnt genes and breast cancer. Cancer J Clin 1999, 49, 33–44.
   PubMedGoogle Scholar
• Huang, C.L.; Liu, D.; Nakano, J.; Ishikawa, S.; Kontani, K.; Yokomise, H. Wnt-5a expression is associated with the tumor proliferation and the stromal vascular endothelial growth factor—an expression in non-small cell lung cancer. J Clin Oncol 2005, 23, 8765–8773.
   PubMed Web of Science ®Google Scholar
• Lejeune, S.; Huguet, E.L.; Hamby, A.; Poulsom, R.; Harris, A.L. Wnt-5a cloning, expression, and upregulation in human primary breast cancers. Clin Cancer Res 1995, 1, 215–222.
   PubMed Web of Science ®Google Scholar
• Saitoh, T.; Mine, T.; Katoh, M. Frequent upregulation of Wnt-5A mRNA in primary gastric cancer. Int J Mol Med 2002, 9, 515–519.
   PubMed Web of Science ®Google Scholar
• Liang, H.; Chen, Q.; Coles, A.H.; et al. Wnt-5a inhibits B cell proliferation and functions as a tumor suppressor in hematopoietic tissue. Cancer Cell 2003, 4, 349–360.
   PubMed Web of Science ®Google Scholar
• Blanc, E.; Roux, G.L.; Benard, J.; Raguenez, G. Low expression of Wnt-5a gene is associated with high-risk neuroblastoma. Oncogene 2005, 24, 1277–1283.
   PubMed Web of Science ®Google Scholar
• Leris, A.C.; Roberts, T.R.; Jiang, W.G.; Newbold, R.F.; Mokbel, K. Wnt5A expression in human breast cancer. Anticancer Res 2005, 25, 731–734.
   PubMed Web of Science ®Google Scholar
• Kremenevskaja, N.; Wasielewski, R.; Rao, A.S.; Schofl, C.; Andersson, T.; Brabant, G. Wnt-5a has tumor suppressor activity in thyroid carcinoma. Oncogene 2005, 24, 2144–2154.
   PubMed Web of Science ®Google Scholar
• Ying, J.; Li, H.; Yu, J.; Ka Man, Ng.; Poon, F.F.; Wong, S.C.; Chan, A.T.C.; Sung, J.J.Y.; Tao, Q. Wnt-5a exhibits tumor-suppressive activity through antagonizing the Wnt/B-catenin signaling, and is frequently methylated in colorectal cancer. Clin Cancer Res 2008, 14, 55–61.
   PubMed Web of Science ®Google Scholar
• Kawano, Y.; Kypta, R. Secreted antagonists of the Wnt signalling pathway. J Cell Sci 2003, 116, 2627–2634.
   PubMed Web of Science ®Google Scholar
• Hsieh, S.Y.; Hsieh, P.S.; Chiu, C.T.; Chen, W.Y. Dickkopf-3/REIC functions as a suppressor gene of tumor growth. Oncogene 2004, 23, 9183–9189.
   PubMed Web of Science ®Google Scholar
• Suzuki, H.; Watkins, D.N.; Jair, K.W.; Schuebel, K.E.; Markowitz, S.D.; Chen, W.D.; Pretlow, T.P.; Yang, B.; Akiyama, Y.; Van Engeland, M.; Toyota, M.; Tokino, T.;Hinoda, Y.; Imai, K.; Herman, J.G.; Baylin, S.B. Epigenetic inactivation of SFRP genes allows constitutive Wnt signaling in colorectal cancer. Nat Genet 2004, 36, 417– 422.
   PubMed Web of Science ®Google Scholar
• Kobayashi, K.; Ouchida, M.; Tsuji, T.; Heike, T.; Nakahata, T. Reduced expression of the REIC/Dkk-3 gene by promoterhypermethylation in human tumor cells. Gene 2002, 282, 151–158.
   PubMed Web of Science ®Google Scholar
• Hsieh, J.C.; Kodjabachian, L.; Rebbert, M.L.; Rattner, A.; Smallwood, P.; Samos, C.H.; Nusse, R.; Dawid, I.B.; Nathans, J. A new secreted protein that binds to Wnt proteins and inhibits their activities. Nature 1999, 398, 431–436.
   PubMed Web of Science ®Google Scholar
• Mazieres, J.; He, B.; You, L.; Xu, K.; Kuchenbecker, D.; Raz, B.; Jablons, D. Wnt inhibitory factor-1 is silenced by promoter hypermethylation in human lung cancer. Cancer Res 2004, 64, 4717–7420.
   PubMed Web of Science ®Google Scholar
• Taniguchi, H.; Yamamoto, H.; Hirata, T. Frequent epigenetic inactivation of Wnt inhibitory factor-1 in human gastrointestinal cancers. Oncogene 2005, 24, 7946–7952.
   PubMed Web of Science ®Google Scholar
• Wissmann, C.; Wild, P.J.; Kaiser, S.; Roepcke, S.; Stoehr, R.; Woenckhaus, M.; Hartmann, A.; Knuechel, R.; Rosenthal, A.; Pilarsky, C. WIF-1, a component of the Wnt pathway, is downregulated in prostate, breast, lung, and bladder cancers. J Pathol 2003, 201, 204–212.
   PubMed Web of Science ®Google Scholar
• Chan, S.L.; Cui, Y.; van Hasselt, A.; Li, H.; Srivastava, G.; Jin, H.; Ng, K.M.; Wang, Y.; Lee, K.Y.; Tsao. G.S.; Zhong, S.; Robertson, K.D.; Rha, S.Y.; Chan, A.T.; Tao, Q. The tumor suppressor Wnt inhibitory factor1 is frequently methylated in nasopharyngeal and esophageal carcinomas. Lab Invest 2007, 87, 644– 650.
   PubMed Web of Science ®Google Scholar
• Zeng, Z.Y.; Zhou, Y.H.; Zhang, W.L.; Xiong, W.; Fan, S.Q.; Li, X.; Wu, M.H.; Yang, Y.X.; Huang, C.; Cao, L. Gene expression profiling of nasopharyngeal carcinoma reveals the abnormally regulated Wnt signaling pathway. Hum Pathol 2007, 38, 120– 133.
   PubMed Web of Science ®Google Scholar
• Shi, W.; Bastianutto, C.; Li, A.; Perez-Ordonez, B.; Ng, R.; Chow, K.Y.; Zhang, W.; Jurisica, I.; Lo, K.W.; Bayley, A.; Kim, J.; O’Sullivan, B.; Siu, L.; Chen, E.; Liu, FF. Multiple dysregulated pathways in nasopharyngeal carcinoma revealed by gene expression profiling. Int J Cancer 2006, 119, 2467–2475.
   PubMed Web of Science ®Google Scholar
• Sobin, L.H.; Wittekind, C.H. International Union Against Cancer Classification and TNM Classification of Malignant Tumours, Ed. 5. New York: Wiley-Liss, 1997, 25–32.
   Google Scholar
• Herman, J.G.; Graff, J.R.; Myo, H.S.; Nelkin, B.D.; Baylin, S.B. Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc Natl Acad Sci USA 1996, 93, 9921– 9926.
   PubMedGoogle Scholar
• Palmisano, W.A.; Divine, K.K.; Saccomanno, G.; Gilliland, F.D.; Baylin, S.B.; Herman, J.G.; Belinsky, S.A. Predicting lung cancer by detecting aberrant promoter methylation in sputum. Cancer Res 2000, 60, 5954–5958.
   PubMed Web of Science ®Google Scholar
• Urakami, S.; Shiina, H.; Enokida, H.; Kawakami, T.; Tokizane, T.; Ogishima, T.; Tanaka, Y.; Ogishima, T.; Tanaka, Y.; Li, L.C.; Ribeiro Filho, L.A.; Terashima, M.; Kikuno, N. Epigenetic inactivation of Wnt Inhibitory Factor-1 plays an important role in bladder cancer through aberrant canonical Wnt/βcatenin signaling pathway. Hum Cancer Biol 2006, 12, 383–391.
   Google Scholar
• Reguart, N.; He, B.; Xu, Z.; You, L.; Lee, A.Y.; Mazieres, J. Cloning and characterization of the promoter of humain Wnt inhibitory factor-1. Biochem Biophys Res Commun 2004, 323, 229–234.
   Google Scholar
• Livak, K.J.; Thomas, D.S. Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔCT method. Methods 2001, 25, 402–408.
   Google Scholar
• Chou, J.; Chou, M.S., Yu Ching, L.; Jae Kim, M.D.; Liang, Y.; Zhidong, Xu; He, B.; David, M.; Jablons, B. Nasopharyngeal carcinoma, review of the molecular mechanisms of tumorigenesis. Clin Rev 2008, 10, 946–963.
   Google Scholar
• Karim, R.; Tse, G.; Putti, T.; Richard, A.; Scolyer, C.; Soon, L. The significance of the Wnt pathway in the pathology of human cancers. Pathology 2004, 36, 120–128.
   Google Scholar
• Lin, Y.C.; You, L.; Xu, Z.; He, B.; Mikami, I.; Thunga, E.; Chou, J.; Kuchenbecker, K.; Kim, J.; Raz, D.; Yang, C.T.; Chen, J.K.; Jablons, D.M. Wnt signaling activation and WIF-1 silencing in nasopharyngeal cancer cell lines. BBRC 2005, 12, 635–640.
   Google Scholar
• Khabir, A.; Karray, H.; Rodriguez, S.; Rosé, M.; Daoud, J.; Frikha, M.; Boudawara, T.; Middeldorp, J.; Jlidi, R.; Busson, P. EBV latent membrane protein 1 abundance correlates with patient age but not with metastatic behavior in north African nasopharyngeal carcinomas. Virology J 2005, 39, 1–7.
   Google Scholar
• Fendri, A.; Khabir, A.; Hdri-Guiga, B.; Sellami-Boudaouara, T.; Ghorbel, A.; Drira, M.; Daoud, J.; Frikha, M.; Gargouri, A.; Mokdad-Gargouri, R. Overexpression of COX-2 and LMP1 are correlated with lymph node in Tunisian NPC patients. Oral Oncol 2008, 44, 710–715.
   Google Scholar
• Tsai, C.L.; Li, H.P.; Lu, Y.J.; Hsueh, C.; Liang, Y.; Chen, C.L.; Tsao, S.W.; Tse, K.P.; Yu, J.S.; Chang, Y.S. Activation of DNA methyltransferase 1 by EBV LMP1 involves c-Jun NH(2)-terminal kinase signaling. Cancer Res 2006, 66, 11668–11676.
   Google Scholar